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Lamellae lead the way
 
pen any cell biology text and it is
clear that lamellipodia, the ruffled
edges of motile cells, initiate move-
ment. So it may come as a surprise that Gupton
et al. can disrupt this domain without block-
ing cell movement (page 619). In fact, cells
move faster without lamellipodia. The driving
force for movement appears to come from
the lamella, the structure that lies just proximal
to the lamellipodium.
Previously, the team examined the
lamella and lamellipodia using quantitative
fluorescent speckle microscopy (qFSM), a
technique that allows for deconvolution of
images of physically overlapping cell domains.
The domains have distinct molecular compo-
nents, filament–assembly kinetics, and motion.
Moreover, although the lamellipodia moved
forward and backward repeatedly in the axis
of cell movement, the team saw hints that
cells made forward progress only when the
lamella moved forward.
To find out if lamellipodia are required
for movement, the team injected skeletal
muscle tropomyosin into epithelial cells in a
wound-healing model. Tropomyosin normally
resides in lamellae and is excluded from lamelli-
podia. Increasing the amount of tropomyosin
O
 
A stalled fork stalls recombination
 
omologous recombination does not rescue stalled replication forks during
S phase, report Meister et al. on page 537. Rather they find that replication and
recombination are separated in terms of when and where they occur. If inappro-
priate recombination does occur when replication is stalled, replication forks fall apart.
Researchers have debated whether homologous recombination, which is
required for double-strand break repair, is also used to resolve stalled replication
forks. However, because the S- and G2/M-phase checkpoints share molecular
components in budding yeast, the question has been difficult to answer.
Now, Meister et al. test the question in fission yeast, where the checkpoints are
molecularly distinct and therefore can be separated. When they added hydroxyurea
to wild-type cells, thus depleting DNA precursors and stalling replication, the recom-
bination protein Rad22 did not aggregate on the chromosomes. However, Rad22
foci did appear on chromosomes in cells deficient for the S-phase checkpoint
component cds1. Furthermore, transferring the cells to fresh media rescued wild-
type cells, but not cds1 mutants. 2D gel analysis of the replication forks showed that
the fork structure decayed in cds1 mutant cells, but maintained normal shapes in
H
The separation of replication (green) and 
recombination (red) is lost in cells deficient 
in the S-phase checkpoint (shown).
 
wild-type cells. In both experiments, cells carrying mutations in the recombination protein rhp51 behaved like wild-type cells.
The researchers conclude that part of the role of the S-phase checkpoint is to prevent inappropriate—and damaging—
recombination during the replication process. cds1 is a protein kinase and Meister et al. are now working to learn whether
it blocks recombination by directly phosphorylating recombination proteins. 
 
pushed it into lamellipodia and disrupted
resident molecules, including Arp2/3 and
ADF/cofilin, which are concentrated in lamelli-
podia but not in lamellae. Video qFSM showed
that excess tropomyosin disrupted actin
treadmilling, which is a critical component of
lamellipodial function. By contrast, retrograde
actin flow in the lamella was not blocked under
these conditions. Cells with elevated tropo-
myosin had more persistent leading edge
movement, less retraction, and doubled their
migration speed relative to untreated cells.
Adhesion proteins accumulate at the
junction between the lamellipodia and the
lamella in untreated cells. In treated cells
the contraction of the lamella’s actin filaments
appeared to be sufficient to pull the rear of the
cell toward these adhesion junctions while
the leading edge was pushed forward.
Gupton et al. hypothesize that lamelli-
podia are involved in rapid response to extra-
cellular cues and setting up directionality. If
that’s true, then cells treated with tropomyosin
would be less responsive to a chemotactic
gradient. The cells used in the current wound
model have only one direction in which to
go, which could be why they move normally
without lamellipodia. 
The localization of Arp2/3 (white) 
in lamellipodia (top) is disrupted by 
tropomyosin (bottom).
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